Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 9051–9100 of 18658
The Board of Directors of Clearwater Paper Corporation (the “Company”) elected Sherri J. Baker as the Company’s Senior Vice President, Chief Financial Officer and designated her as the Company’s principal financial officer, effective August 14, 2023.
On March 2, 2023, Dell Technologies Inc. (the “Company”) filed a Current Report on Form 8-K that reported that Yvonne McGill, who currently serves as the Company’s Corporate Controller, was appointed as the Company’s Chief Financial Officer, effective as of August 5, 2023 (the “Start Date”).
On August 3, 2023, the Board of Directors (the “Board”) of The Beauty Health Company (the “Company”) appointed Michael Monahan, age 51, as Chief Financial Officer of the Company, effective August 10, 2023 (the “Effective Date”).
Mr. Monahan will replace Liyuan Woo, who will step down from the role of Chief Financial Officer, effective as of the Effective Date.
On August 4, 2023, Salvatore Galletti, President and Chief Executive Officer of Tattooed Chef, Inc., a Delaware corporation (the “Company”) and Chairman of the Board of Directors, resigned from the President and Chief Executive Officer position effective immediately.
As previously reported, Ms. Glancy’s employment with the Company is expected to terminate effective August 31, 2023.
the Company’s board of directors appointed Randy D. Uglem, the Company’s Senior Vice President of Lending, to succeed Kristine A. Glancy as President and Chief Executive Officer, effective August 4, 2023.
The Board has appointed Lori A. Flees, the Company’s President, Retail Services, to succeed Mr. Mitchell as CEO, effective October 1, 2023.
Samuel J. Mitchell, Jr., the Company’s Chief Executive Officer (“CEO”) and a member of the Board of Directors (the “Board”), notified the Company’s Board on August 3, 2023 of his intention to retire as CEO and as a member of the Board, effective as of the close of business on September 30, 2023.
On August 7, 2023, New Peoples Bankshares, Inc. (the “Company”), the holding company of New Peoples Bank, Inc. (the “Bank”), issued a press release announcing that C. Todd Asbury, the President and Chief Executive Officer of the Company and the Bank, will step down from his current Bank positions effective December 1, 2023 and his current Company positions effective May 31, 2024.
On August 2, 2023, the Company also announced that the Board appointed Fareeha Khan, the Company’s current Vice President of Finance, to serve as Chief Financial Officer and principal financial officer, effective August 25, 2023.
On August 2, 2023, Bradley S. Little submitted, and the board of directors (the “Board”) of DIRTT Environmental Solutions Ltd. (the “Company”) accepted, his resignation as Chief Financial Officer of the Company, effective August 25, 2023.
On August 4, 2023, the Board appointed Thomas W. Tedford to succeed Boris Elisman as CEO effective October 1, 2023.
On August 4, 2023, Boris Elisman, Chairman and Chief Executive Officer, notified the Board of Directors (the "Board") of ACCO Brands Corporation (the "Company") of his intention to resign as Chief Executive Officer ("CEO") of the Company effective October 1, 2023, and his intention not to stand for re-election to the Board at the Company's 2024 Annual Meeting of Stockholders.
The Company announced today that Daphne Quimi, the Company’s Chief Financial Officer, notified the Company on August 3, 2023 that she intends to retire before the end of 2023.
Mr. W. Erik Carlson will step down as Chief Executive Officer of DISH as of the Effective Time.
On August 7, 2023, the Board approved the appointment of Mr. Hamid Akhavan, the current President and Chief Executive Officer of EchoStar, as the President and Chief Executive Officer of DISH and a member of the Board effective as of the date on which the Effective Time occurs.
On August 4, 2023, Lynn Blake notified Nuwellis, Inc., a Delaware corporation (the “ Company ”) of her decision to resign as the Chief Financial Officer of the Company.
The Company intends to appoint Rob Scott, the Company’s current Senior Finance Director, as its new Chief Financial Officer, effective September 2, 2023.
On August 8, 2023, Elevance Health, Inc. (the “Company”) announced that Mark Kaye has been named Executive Vice President and Chief Financial Officer (“CFO”) of the Company, effective November 1, 2023 (the “Transition Date”).
Mr. Kaye succeeds John Gallina, who, after nearly thirty years of dedicated services to the Company, has decided to retire as CFO.
On August 7, 2023 (the “Meek Separation Date”), David Meek resigned as a member of the Company’s board of directors and as the Company’s Chief Executive Officer and principal executive officer.
The Company’s board of directors has, effective as of the Meek Separation Date, appointed Charles M. Baum, M.D., Ph.D., in addition to his other titles, as Interim Chief Executive Officer of the Company and as the Company’s principal executive officer.
On August 7, 2023, John Collins was appointed as Interim Chief Executive Officer and principal executive officer of the Company, effective immediately.
Mr. LoCascio has assumed the role of Special Advisor through December 31, 2023 and shall no longer serve as Chief Executive Officer of the Company, effective August 7, 2023.
On August 7, 2023, RingCentral, Inc. (the “Company”) announced that the Company has appointed Tarek Robbiati, a member of the Company’s board of directors (the “Board”), to succeed Vladimir Shmunis as the Company’s Chief Executive Officer effective August 28, 2023 (the “Effective Date”).
announced the appointment of Mr. George Ng as its Chief Executive Officer and a director.
Effective upon the closing of the Business Combination, Michael D. Winston will be appointed to serve as Jet.AI’s Executive Chairman and will be appointed to serve as Jet.AI’s interim Chief Executive Officer (“CEO”)
and George Murnane will serve as Jet.AI’s interim Chief Financial Officer (“CFO”)
Effective August 14, 2023, R. Scott Blackley will become the Company’s Chief Financial Officer (“CFO”).
Mr. Siddhartha Sankaran will remain CFO through that date.
on July 26, 2023, Andrew Brown was appointed as a director and Chief Executive Officer, Chief Financial Officer and Secretary of the Company.
the Board plans to appoint Christine Barone, President of the Company, to the role of Chief Executive Officer and President
Joth Ricci’s planned January 2024 departure from his current role of Chief Executive Officer of the Company.
On August 4, 2023, Mr. Kuta was appointed as the sole President and CEO and a director of the Company
As of August 4, 2023, Tesla, Inc. (“Tesla”) appointed Vaibhav Taneja as Chief Financial Officer in addition to his current role as Chief Accounting Officer, to succeed Zachary Kirkhorn.
Mr. Kirkhorn stepped down as of August 4, after a thirteen-year tenure with the company, the last four years of which he has served as Master of Coin and Chief Financial Officer.
Raymond Silcock, ahs resigned, effective August 3, 2023, for person reasons.
Lisa Gainsborg will serve as Interim Chief Financial Officer effective immediately.
the Board unanimously appointed Kevin J. Harrill, 46, to succeed Mr. Strawbridge as the Company’s Senior Vice President, Chief Financial Officer, and Treasurer, effective August 31, 2023.
Philip O. Strawbridge, Senior Vice President, Chief Financial Officer, Chief Administrative Officer and Treasurer of Centrus Energy Corp. (the “Company”), provided notice of his decision to retire from the Company effective December 31, 2023.
On August 3, 2023, Bellerophon Therapeutics, Inc. (the “Company”) entered into a transition and separation agreement with Peter Fernandes, the Company’s Chief Executive Officer
On August 3, 2023, Farmer Bros. Co., a Delaware corporation (the “Company”) and Scott Drake, the Company’s Chief Financial Officer, agreed that Mr. Drake’s employment with the Company will be terminated, without cause, effective October 1, 2023.
On August 2, 2023, Michael Levitt resigned from his role as Chief Executive Officer (“CEO”) of Core Scientific, Inc. (the “Company”), effective as of August 2, 2023.
On August 2, 2023, the Board appointed Adam Sullivan to serve as interim CEO, effective as of August 2, 2023.
Effective upon the closing of the Business Combination, Allurion entered into a new employment agreement with Mr. Geberth, pursuant to which Allurion will continue to employ Mr. Geberth as Chief Financial Officer on an “at will” basis.
Effective upon the closing of the Business Combination, Allurion entered into a new employment agreement with Dr. Gaur, pursuant to which Allurion will continue to employ Dr. Gaur as Chief Executive Officer on an “at will” basis.
Tengjun Biotechnology Corp. wishes to announce that Mr. Xianchang Ma, the Chief Executive Officer, Chief Financial Officer and Director of the Company, passed away on August 3, 2023.
Tengjun Biotechnology Corp. wishes to announce that Mr. Xianchang Ma, the Chief Executive Officer, Chief Financial Officer and Director of the Company, passed away on August 3, 2023.
the Board of Directors (the “Board”) of the Company appointed Bryon T. McGregor to serve as the Company’s President and Chief Executive Officer.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.